tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Sagimet Biosciences enters global license agreement with TAPI
PremiumCompany AnnouncementsSagimet Biosciences enters global license agreement with TAPI
25d ago
Sagimet Biosciences announces China’s NMPA accepted NDA for denifanstat
Premium
The Fly
Sagimet Biosciences announces China’s NMPA accepted NDA for denifanstat
1M ago
Buy Rating for Sagimet Biosciences: Promising Pipeline Developments and Strong Financial Position
Premium
Ratings
Buy Rating for Sagimet Biosciences: Promising Pipeline Developments and Strong Financial Position
1M ago
Optimistic Buy Rating for Sagimet Biosciences Driven by Promising Clinical Progress and Strong Financial Position
PremiumRatingsOptimistic Buy Rating for Sagimet Biosciences Driven by Promising Clinical Progress and Strong Financial Position
2M ago
Sagimet Biosciences Reports Q3 Results and Updates
Premium
Company Announcements
Sagimet Biosciences Reports Q3 Results and Updates
2M ago
Sagimet Biosciences reports Q3 EPS (40c), consensus (39c)
Premium
The Fly
Sagimet Biosciences reports Q3 EPS (40c), consensus (39c)
2M ago
Sagimet Biosciences initiated with a Buy at Clear Street
PremiumThe FlySagimet Biosciences initiated with a Buy at Clear Street
3M ago
Sagimet Biosciences to present Phase 2b FASCINATE-2 study results
Premium
The Fly
Sagimet Biosciences to present Phase 2b FASCINATE-2 study results
3M ago
Buy Rating for Sagimet Biosciences: Promising Clinical Developments and Synergistic Therapy Potential
Premium
Ratings
Buy Rating for Sagimet Biosciences: Promising Clinical Developments and Synergistic Therapy Potential
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100